The announcement below was recently put on hold. Below are several related news items:
1) https://www.addictioncenter.com/news/2021/01/biden-canceling-trumps-opioid-treatment-prescriptions/
2) https://www.washingtonpost.com/health/2021/01/27/biden-kills-buprenorphine-waiver/
The U.S. Department of Health and Human Services announced that it will publish new guidelines that will expand access to medication-assisted treatment for opioid use disorder by exempting physicians from certain certification requirements necessary for prescribing buprenorphine.
The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder include an exemption from certain requirements under the Controlled Substances Act for physicians who are licensed under state law and possess DEA registration. Additional details of the exemption include:
A working group will monitor implementation and results of the guidelines, including potential changes in medication diversion. Ohio physicians interested in obtaining an MAT waiver can get free training from the Providers Clinical Support System.